STK11 and non-small cell lung carcinoma: Inactivation of the tumor suppressor Serine/Threonine kinase 11 (STK11/LKB1), frequently observed in KRAS-mutant NSCLC, is strongly associated with primary resistance to ICIs, even in tumors with TMB-H (27, 28).